Palomino Laboratories Inc. (PALX)

CIK 1938569 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Palomino Laboratories Inc..

Recent SEC filings

FiledFormAccession number
Aug 21, 2026SCHEDULE 13D/A0001493152-26-039653
Aug 5, 20268-K0001493152-26-036127
Aug 5, 202610-Q0001493152-26-036061
Aug 4, 202640001493152-26-035982
Jul 16, 20268-K0001493152-26-033505
May 15, 202610-Q0001493152-26-023678
May 5, 20268-K0001493152-26-021282
May 1, 2026D0001493152-26-020909
Apr 24, 20268-K0001493152-26-018963
Apr 20, 202640001493152-26-018116
Apr 20, 202640001493152-26-018119
Apr 9, 20268-K0001493152-26-015767
Mar 31, 202610-K0001493152-26-014270
Feb 12, 2026424B30001493152-26-006261
Feb 9, 2026EFFECT9999999995-26-000481
Jan 23, 2026S-10001493152-26-003287
Nov 14, 202510-Q0001493152-25-023285
Oct 30, 20258-K0001493152-25-020229
Oct 27, 202540001493152-25-019755
Oct 27, 2025SCHEDULE 13D0001493152-25-019712
Oct 14, 2025D0001493152-25-017841
Oct 9, 202540001493152-25-017607
Oct 9, 202540001493152-25-017571
Oct 9, 202540001493152-25-017568
Oct 8, 2025SCHEDULE 13D0001493152-25-017501